Vantive Launches HomeAdvantage Ecosystem to Expand Access to Home Dialysis
Table of Contents
A new, fully-integrated system aims to dramatically improve the home dialysis experience, addressing a critical gap in care for millions globally. Vantive, a leader in vital organ therapy with a 70-year history of kidney care innovation, today announced the launch of HomeAdvantage, a comprehensive ecosystem designed to support patients undergoing home dialysis therapies.
Addressing a Critical Need in Home Dialysis Adoption
Despite the well-documented clinical and quality-of-life benefits, home dialysis – specifically peritoneal dialysis (PD) – remains considerably underutilized. Currently, only approximately 11% of dialysis patients worldwide receive PD at home, according to recent data. HomeAdvantage is specifically engineered to overcome the barriers preventing wider adoption, making home-based therapy more accessible, manageable, and enduring for both patients and their care teams.
How HomeAdvantage Works: A Connected Ecosystem
HomeAdvantage encompasses a range of services, including PD therapies, streamlined supply ordering, dedicated technical support, and comprehensive educational programs. At the heart of the system is Vantive CONNECT, a suite of digital solutions designed to keep patients and care teams connected, informed, and confident throughout the entire home dialysis process.
The system’s key components include:
- Clinical Enablement: The Sharesource Connectivity Platform, Vantive’s two-way remote monitoring system, provides healthcare
Future of Home Dialysis
Vantive’s commitment to transforming the dialysis experience is underscored by a previously announced $1 billion innovation investment over the next five years. This investment will fuel the continued development of HomeAdvantage and other patient-centric therapy innovations.
“At Vantive, we believe where and how dialysis is delivered matters profoundly to patient outcomes and quality of life,” stated Chris toth, CEO of Vantive. “By meeting patients where they are – at home – with one connected therapy ecosystem that brings together innovative products, digital solutions and advanced services, we are confident we can definitely help more patients start and stay on therapy. With greater therapy accessibility, adherence and personalization, we can help improve clinical outcomes and truly expand possibilities for dialysis patients and care teams around the world.”
one medical professional echoed this sentiment, noting that expanding home dialysis adoption requires a comprehensive support system. “Things that are crucial for the delivery of automated peritoneal dialysis include having a remote monitoring platform, timely patient communications with clinical staff, proactive assessment of treatment data, as well as visual representations of treatment data trends,” said Dr. Osama el Shamy, Associate Professor of Clinical Medicine at the University of Pennsylvania, and Medical Director at the DaVita Cedar Grove dialysis unit in Philadelphia, Pennsylvania. “This would create an environment where both patients and care teams can manage the complexities of home dialysis more effectively.”
Showcasing HomeAdvantage at Kidney Week 2025
HomeAdvantage with Vantive CONNECT will be showcased at the American Society of Nephrology’s kidney Week 2025, further demonstrating Vantive’s dedication to addressing critical barriers to therapy access and adoption.
Vantive’s overarching mission is to extend lives and expand possibilities for patients globally. With over 1 million patient touchpoints each day, the company is focused on elevating the dialysis experience through digital solutions and advanced services, while also expanding its focus beyond kidney care to transform vital organ therapies. The company aims to deliver therapies that seamlessly integrate into both provider practices and patient lives,fostering greater versatility,efficiency,and ultimately,longer,fuller lives for those affected by organ failure.
For more details, visit www.vantive.com and follow Vantive on LinkedIn, X, Facebook, Instagram, and YouTube.
